IHE icon

iShares US Pharmaceuticals ETF
IHE

Overview Fund Activity

95 hedge funds and large institutions have $348M invested in iShares US Pharmaceuticals ETF in 2017 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 24 increasing their positions, 37 reducing their positions, and 9 closing their positions.

Holders
95
Holders Change
-2
Holders Change %
-2.06%
% of All Funds
2.37%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
7
Increased
24
Reduced
37
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$34.6M
2
MML Investors Services
2
MML Investors Services
Massachusetts
$5.41M
3
CS
3
Credit Suisse
Switzerland
$6.03M
4
Bank of America
4
Bank of America
North Carolina
$26.7M
5
FDCDDQ
5
Federation des caisses Desjardins du Quebec
Quebec, Canada
$622K

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$567K
2
MTWSIF
2
Mivtachim The Workers Social Insurance Fund
Israel
$0
3
MIAN
3
Mariner Independent Advisor Network
Kansas
$0
4
TSS
4
Two Sigma Securities
New York
$570K
5
Royal Bank of Canada
5
Royal Bank of Canada
Ontario, Canada
$4.1M
Name Holding Trade Value Shares
Change 		Shares
Change %
NFG
101
Next Financial Group
Texas
– -$16K -312 Closed
GWM
102
Geneos Wealth Management
Colorado
– -$9K -192 Closed
AssetMark Inc
103
AssetMark Inc
California
– -$2K -48 Closed
1 2 3 4
5